Whatever the case, the fundamentals of a politically supportive backdrop for Novavax’s traditional approach to vaccines could easily boost NVAX stock under Trump’s second administration. With that in ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

MicroStrategy is targeting a capital raise of up to $2 billion to continue to strengthen its balance sheet and acquire more the business software company announced. The capital raise will be through ...

From mortgage rates to housing affordability, the real estate market is poised for some big changes in 2025. Founder of RexMont Real Estate Adriano Tori joined Good Day Seattle to explain what buyers ...

Preferred stock is often described as a stock that acts like a bond. Investors value them for their steady income, not the potential market price increases.

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look ...

ICU Medical's shares soared in 2024 with a strong rebound forecast. Read why ICUI stock remains intriguing for investors amid ...

By trading at a significant discount to its 2022 highs, Pfizer stock now offers investors a rare opportunity to buy this industry giant at a discount. Besides the price action, discounts are coming ...

Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the ...

Here's what to expect from the stock market, along with some of Wall Street's hottest trends and most influential businesses, ...

Takeda-backed Ascentage Pharma Group (AAPG) has filed to raise up to $100M through a U.S. initial public offering. The ...